ArticleJournal of physiology and biochemistry2026
Global deletion of the triglyceride-synthesizing enzyme TMEM68 disrupts hepatic lipid homeostasis in mice.
Article in Journal of physiology and biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Transmembrane protein 68 (TMEM68) mediates triacylglycerol (TAG) synthesis in mammals independently of canonical diacylglycerol acyltransferase (DGAT) 1 and DGAT2 enzymes. However, the in vivo roles of TMEM68 including its contribution to tissue-specific TAG formation remain largely elusive. In this study, we used a global Tmem68 knockout mouse model to investigate the impact of TMEM68 deficiency on lipid and energy metabolism of the liver. We found that loss of TMEM68 leads to a transient reduction in hepatic TAG storage and circulating ketone bodies approximately 4 weeks after birth. TMEM68-deficient livers exhibited reduced abundance of distinct acylglycerols and fatty acids, altered glycerophospholipid composition, and accumulation of polar ether lipids. Primary TMEM68-deficient hepatocytes also had reduced TAG and lipid droplet contents. RNA sequencing revealed that genes involved in multiple fatty acid metabolic processes and ketogenesis were repressed in Tmem68 knockout livers. Furthermore, Tmem68 ablation reduced hepatic cholesterol esters and modulated bile acid composition. In summary, our study identifies TMEM68 as a positive regulator of hepatic storage lipid levels and demonstrates a multifaceted embedding of the enzyme in hepatic lipid and energy metabolic pathways.
Indexed as
Identifiers
42853368What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.